| CHEK2 |
|---|
| Symbol | CHEK2 |
|---|
| Full Name | Checkpoint Kinase 2 |
|---|
| Chromosome | 22q12.1 |
|---|
| NCBI Gene ID | [1111](https://www.ncbi.nlm.nih.gov/gene/1111) |
|---|
| OMIM | [604373](https://www.omim.org/entry/604373) |
|---|
| Ensembl | [ENSG00000183765](https://ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000183765) |
|---|
| UniProt | [O96017](https://www.uniprot.org/uniprot/O96017) |
|---|
| Associated Diseases | [Alzheimer's disease](/diseases/alzheimers-disease), [Parkinson's disease](/diseases/parkinsons-disease), Li-Fraumeni Syndrome, Cancer |
|---|
CHEK2 (Checkpoint Kinase 2) encodes a serine/threonine protein kinase that serves as a critical mediator of the DNA damage response and cell cycle regulation. First identified as a key effector of ATM kinase in response to DNA double-strand breaks, CHEK2 has evolved from a cancer-related gene to a significant player in neurodegenerative disease pathogenesis ahn2000.
The central role of CHEK2 in neuronal survival stems from its position at the intersection of DNA repair, cell cycle control, and apoptosis pathways. In post-mitotic neurons that cannot proliferate, inappropriate activation of cell cycle checkpoint proteins can trigger programmed cell death, contributing to the progressive neuronal loss characteristic of Alzheimer's disease (AD) and Parkinson's disease (PD) mattson2000.
This page covers CHEK2's molecular biology, its role in neuronal DNA damage response, disease associations, signaling pathways, therapeutic implications, and key research findings.
¶ Gene and Protein Structure
The CHEK2 gene is located on chromosome 22q12.1 and spans approximately 54 kb of genomic DNA. The gene consists of 14 exons that encode a protein of 543 amino acids with a molecular weight of approximately 60 kDa. The gene structure reflects its evolutionary conservation and functional complexity.
¶ Protein Domains
The CHEK2 protein contains several critical functional domains stracker2013:
-
N-terminal SQ/TQ cluster domain (SCD): Contains multiple serine-glutamine (SQ) and threonine-glutamine (TQ) motifs that serve as phosphorylation sites for ATM and ATR kinases. This region is essential for DNA damage-induced activation.
-
Kinase domain (KD): The central catalytic domain (residues 219-431) shares homology with other PIKK family kinases including ATM, ATR, and DNA-PK. The kinase domain contains the activation loop and the conserved residues required for ATP binding and phosphate transfer.
-
C-terminal regulatory domain: Contains a FHA (forkhead-associated) domain that mediates protein-protein interactions with other checkpoint and repair proteins. This domain is essential for substrate recognition and localization to sites of DNA damage.
-
Nuclear localization signals (NLS): Multiple basic regions facilitate import of CHEK2 into the nucleus, where it performs its checkpoint functions.
CHEK2 interacts with several key proteins:
| Partner |
Interaction |
Function |
| ATM |
Phosphorylation |
Primary activator in response to DSBs |
| TP53 |
Phosphorylation |
Transduction of checkpoint signal |
| Cdc25A/B/C |
Phosphorylation |
Cell cycle arrest |
| BRCA1 |
Direct binding |
DNA repair coordination |
| E2F1 |
Phosphorylation |
Transcription regulation |
| MDC1 |
Direct binding |
DNA damage response scaffold |
The ATM-CHEK2 pathway is the primary signaling cascade responding to ionizing radiation-induced DNA double-strand breaks:
flowchart TD
A["DNA Double-Strand Break"] --> B["MRN Complex"]
B --> C["ATM Autophosphorylation"]
C --> D["ATM Dimer → Monomer"]
D --> E["CHEK2 Recruitment"]
E --> F["ATM Phosphorylates CHEK2"]
F --> G["CHEK2 Autophosphorylation"]
G --> H["Tetramer Formation"]
H --> I["Substrate Phosphorylation"]
I --> J["TP53 Activation"]
I --> K["Cdc25 Inhibition"]
I --> L["Cell Cycle Arrest"]
I --> M["DNA Repair or Apoptosis"]
The pathway operates as follows thiels2008:
- Signal detection: The MRN complex (MRE11-RAD50-NBS1) recognizes DNA double-strand breaks and recruits ATM
- ATM activation: Autophosphorylation of ATM at Ser198 converts inactive dimers to active monomers
- CHEK2 recruitment: ATM phosphorylates CHEK2 at Thr68 within its SQ/TQ cluster, creating a binding site for the CHEK2 FHA domain
- CHEK2 activation: Phosphorylated CHEK2 undergoes autophosphorylation at multiple sites, forming active tetramers
- Signal transduction: Active CHEK2 phosphorylates downstream targets including TP53, Cdc25 phosphatases, and transcription factors
Beyond cell cycle arrest, CHEK2 coordinates DNA repair processes martin2006:
- Homologous recombination (HR): CHEK2 phosphorylates BRCA1, promoting its function in error-free repair
- Non-homologous end joining (NHEJ): Modulates DNA-PK activity for alternative repair pathways
- Checkpoint adaptation: After successful repair, CHEK2 helps inactivate the checkpoint and allow cell cycle re-entry
Neurons are particularly vulnerable to DNA damage due to their post-mitotic nature and high metabolic demand iuchi2009:
- Basal DNA damage: Normal neuronal activity generates oxidative DNA lesions that require constant repair
- Limited repair capacity: Unlike proliferating cells, neurons cannot dilute damage through cell division
- Apoptotic vulnerability: If DNA damage exceeds repair capacity, neurons trigger apoptosis through CHK2-TP53 pathways
CHEK2 plays a multifaceted role in Alzheimer's disease pathogenesis mallard1999, canter2008:
AD brains exhibit significant DNA damage:
- Elevated levels of 8-oxoguanine, a marker of oxidative DNA damage
- Accumulation of DNA double-strand breaks in neurons
- Impaired repair of both nuclear and mitochondrial DNA
The mitochondrial dysfunction characteristic of AD generates excessive reactive oxygen species that damage neuronal DNA moreira2010.
Several mechanisms link CHEK2 to AD pathogenesis:
- Chronic activation: Low-level DNA damage in AD brains leads to sustained CHEK2 activation
- p53 hyperphosphorylation: Excessive CHEK2 activity contributes to p53-mediated apoptosis
- Cell cycle re-entry: Aberrant CHEK2 signaling can trigger mature neurons to re-enter the cell cycle, leading to death estus1994
¶ Beta-Amyloid and CHEK2
Amyloid-beta toxicity involves DNA damage:
- Amyloid-beta induces oxidative stress and DNA damage in neurons
- This activates the ATM-CHK2 pathway inappropriately
- Chronic activation leads to neuronal apoptosis rather than survival
CHEK2 is implicated in Parkinson's disease through multiple mechanisms wilson2010, rakovic2011:
PD brains show elevated markers of DNA damage:
- Increased oxidative DNA lesions in substantia nigra neurons
- Impaired repair of mitochondrial DNA
- Vulnerability of dopaminergic neurons to genotoxic stress
The mitochondrial dysfunction in PD creates a vicious cycle:
- Damaged mitochondria produce more reactive oxygen species
- ROS cause additional DNA damage
- DNA damage activates CHEK2, potentially triggering apoptosis in already vulnerable neurons
PD neurons show evidence of cell cycle re-entry martinez2011:
- CHEK2 activation can trigger inappropriate cell cycle progression
- Post-mitotic neurons cannot complete the cell cycle, leading to apoptosis
- This mechanism may contribute to progressive dopaminergic neuron loss
CHEK2 may contribute to motor neuron degeneration:
- DNA damage accumulates in ALS motor neurons
- CHEK2-mediated apoptosis may accelerate neuronal death
- Implicated in both sporadic and familial ALS
CHEK2 dysregulation in HD:
- Mutant huntingtin causes increased DNA damage
- CHEK2 activation contributes to neuronal dysfunction
- Potential therapeutic target for neuroprotection
CHEK2-TP53 represents a critical death pathway in neurons mcneill2011, gao2013:
flowchart TD
A["DNA Damage"] --> B["ATM Activation"]
B --> C["CHEK2 Activation"]
C --> D["TP53 Phosphorylation"]
D --> E["p53 Transcriptional Activation"]
E --> F["PUMA Expression"]
E --> G["BAX Expression"]
E --> H["NOXA Expression"]
F --> I["Mitochondrial Outer Membrane Permeabilization"]
G --> I
H --> I
I --> J["Cytochrome C Release"]
J --> K["Caspase Cascade Activation"]
K --> L["Apoptosis"]
Key pro-apoptotic targets of p53 include:
- PUMA: Direct BAX activator
- BAX: Pore-forming protein
- NOXA: Pro-apoptotic Bcl-2 family member
CHEK2 enforces cell cycle checkpoints copani2008:
- G1/S checkpoint: Phosphorylation of Cdc25A leads to SCF ubiquitin ligase-mediated degradation, preventing S-phase entry
- G2/M checkpoint: Phosphorylation of Cdc25B/C inhibits CDK1 activation, blocking mitosis
- Intra-S checkpoint: Replication stress response
In neurons, checkpoint enforcement has fatal consequences as they cannot complete cell division.
Modulating CHEK2 activity represents a potential neuroprotective strategy copani2008:
- Prevents excessive apoptosis: Blocking CHEK2 activation may protect neurons from DNA damage-induced death
- Promotes DNA repair: By allowing checkpoint adaptation and repair completion
- Considerations: Must balance preventing death while maintaining tumor surveillance
- Enhanced DNA repair: May improve repair capacity in neurons
- Cell cycle control: Helps prevent inappropriate cell cycle re-entry
- Considerations: Over-activation could trigger apoptosis
- Blood-brain barrier: CNS-penetrant CHEK2 modulators needed
- Cell type specificity: Targeting neuronal CHEK2 specifically
- Therapeutic window: Balancing checkpoint function with survival
- Disease stage: Intervention likely most effective early in disease course
| Approach |
Status |
Application |
| ATM inhibitors |
Preclinical |
Potentially protective |
| p53 inhibitors |
Experimental |
May prevent apoptosis |
| Antioxidants |
Clinical trials |
Reduce DNA damage |
| DNA repair enhancers |
Research |
Improve repair capacity |
Chek2-/- mice show:
- Increased tumor predisposition (primarily sarcomas)
- Impaired DNA damage checkpoint
- Enhanced sensitivity to ionizing radiation
- Viable but with increased cancer risk
Neuronal Chek2 deletion studies reveal:
- Enhanced survival after DNA damage
- Impaired checkpoint activation
- Potential for inappropriate cell cycle progression
- Complex phenotype requiring careful interpretation
In AD mouse models:
- CHEK2 activation correlates with disease progression
- Inhibition reduces neuronal apoptosis
- Improves cognitive outcomes in some studies
- Cell type specificity: How does CHEK2 function differ across neuronal subtypes?
- Threshold effects: What level of DNA damage triggers CHEK2-mediated death vs. repair?
- Therapeutic targeting: How to specifically modulate neuronal CHEK2?
- Biomarkers: Are there biomarkers for CHEK2 pathway activation in patients?
- Single-cell analysis: CHEK2 expression in specific neuronal populations
- Epigenetic regulation: How DNA damage affects CHEK2 transcription
- Non-canonical functions: CHEK2 roles beyond checkpoint signaling
- Combination therapies: CHEK2 modulators with other neuroprotective strategies